Karl R. Clauser
Harvard University
H-index: 71
North America-United States
Top articles of Karl R. Clauser
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma | Molecular Cell | Damon A Hofman Jorge Ruiz-Orera Ian Yannuzzi Rakesh Murugesan Adam Brown | 2024/1/18 |
Abstract A038: Non-canonical MHC class I-associated antigens in pancreatic cancer | Cancer Research | Zackery A Ely Zachary J Kulstad Eva K Verzani Jennifer G Abelin Sudarsana Addepalli | 2024/1/16 |
Pan-cancer proteogenomics characterization of tumor immunity | Cell | Francesca Petralia Weiping Ma Tomer M Yaron Francesca Pia Caruso Nicole Tignor | 2024/2/12 |
The HLA-II immunopeptidome of SARS-CoV-2 | Cell reports | Shira Weingarten-Gabbay Da-Yuan Chen Siranush Sarkizova Hannah B Taylor Matteo Gentili | 2024/1/23 |
1040-B Identifying tumor-associated antigens in different stages of multiple myeloma using low input HLA immunopeptidomics | Gabrielle M Hernandez Hannah Taylor Eva K Verzani Claudia Ctortecka David A Berrios Nolasco | 2023/11/1 | |
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation | Cell | Yifat Geffen Shankara Anand Yo Akiyama Tomer M Yaron Yizhe Song | 2023/8/31 |
Sensitive, high-throughput HLA-I and HLA-II immunopeptidomics using parallel accumulation-serial fragmentation mass spectrometry | Molecular & Cellular Proteomics | Kshiti Meera Phulphagar Claudia Ctortecka Alvaro Sebastian Vaca Jacome Susan Klaeger Eva K Verzani | 2023/6/1 |
What can Ribo-seq and proteomics tell us about the non-canonical proteome? | Biorxiv | John R Prensner Jennifer G Abelin Leron W Kok Karl R Clauser Jonathan M Mudge | 2023/5/18 |
Deep learning integrates histopathology and proteogenomics at a pan-cancer level | Cell Reports Medicine | Joshua M Wang Runyu Hong Elizabeth G Demicco Jimin Tan Rossana Lazcano | 2023/9/19 |
Proteogenomic data and resources for pan-cancer analysis | Yize Li Yongchao Dou Felipe Da Veiga Leprevost Yifat Geffen Anna P Calinawan | 2023/8/14 | |
Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues | Nature Communications | Jennifer G Abelin Erik J Bergstrom Keith D Rivera Hannah B Taylor Susan Klaeger | 2023/4/3 |
Systematic Prediction of Minor Histocompatibility Antigens to Inform GvHD Outcomes after Allogeneic Stem Cell Transplantation | Blood | Nicoletta Cieri Nidhi Hookeri Kari Stromhaug Liang Li Julia Keating | 2023/11/28 |
Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin | Cancer cell | Wen-Wei Liang Rita Jui-Hsien Lu Reyka G Jayasinghe Steven M Foltz Eduard Porta-Pardo | 2023/9/11 |
HLA-II immunopeptidome profiling and deep learning reveal features of antigenicity to inform antigen discovery | Immunity | Martin Stražar Jihye Park Jennifer G Abelin Hannah B Taylor Thomas K Pedersen | 2023/7/11 |
The HLA-II immunopeptidome of SARS-CoV-2 (preprint) | Shira Weingarten-Gabbay Da-Yuan Chen Siranush Sarkizova Hannah B Taylor Matteo Gentili | 2023 | |
An Analytic Framework for the Prediction of Gvl Minor Histocompatibility Antigens to Prevent or Treat Post-Transplant Relapse | Blood | Nicoletta Cieri Liang Li Nidhi Hookeri Kari Stromhaug Julia Keating | 2023/11/28 |
What can ribo-seq, immunopeptidomics, and proteomics tell us about the noncanonical proteome? | Molecular & Cellular Proteomics | John R Prensner Jennifer G Abelin Leron W Kok Karl R Clauser Jonathan M Mudge | 2023/9/1 |
Proteomic profiling of extracellular matrix components from patient metastases identifies consistently elevated proteins for developing nanobodies that target primary tumors … | Cancer Research | Noor Jailkhani Karl R Clauser Howard H Mak Steffen Rickelt Chenxi Tian | 2023/6/15 |
Pan-viral ORFs discovery using Massively Parallel Ribosome Profiling | bioRxiv | Shira Weingarten-Gabbay Matthew R Bauer Alexandra C Stanton Susan Klaeger Eva K Verzani | 2023 |
1408 Non-canonical peptide sources broaden the landscape of targetable antigens in pancreatic cancer | Zackery A Ely Zachary J Kulstad Jennifer G Abelin Eva K Verzani Sudarsana Addepalli | 2023/11/1 |
Co-Authors
